American Renal Associates Holdings Inc. (NYSE:ARA) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $24.02 and last traded at $24.36, with a volume of 84,192 shares traded. The stock had previously closed at $26.59.

ARA has been the subject of several research reports. Barclays PLC initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “overweight” rating and a $33.00 price target for the company. SunTrust Banks Inc. initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “buy” rating and a $34.00 price target for the company. Wells Fargo & Co. initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “outperform” rating for the company. Goldman Sachs Group Inc. initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued a “neutral” rating and a $30.00 price target for the company. Finally, Leerink Swann initiated coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They issued an “outperform” rating and a $33.00 price target for the company. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $31.80.

The stock has a market cap of $542.37 million and a P/E ratio of 12.44. The company’s 50 day moving average is $0.00 and its 200 day moving average is $0.00.

American Renal Associates Holdings (NYSE:ARA) last announced its quarterly earnings results on Thursday, May 12th. The company reported $0.16 earnings per share (EPS) for the quarter. The firm earned $172.10 million during the quarter, compared to analyst estimates of $149.30 million. On average, analysts predict that American Renal Associates Holdings Inc. will post $0.88 earnings per share for the current fiscal year.

American Renal Associates Holdings, Inc is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.